tiprankstipranks
Trending News
More News >
Genscript Biotech (HK:1548)
:1548
Hong Kong Market

Genscript Biotech (1548) Financial Statements

Compare
10 Followers

Genscript Biotech Financial Overview

Genscript Biotech's market cap is currently HK$31.17B. The company's EPS TTM is HK$-0.17123420951999999; its P/E ratio is ―; Genscript Biotech is scheduled to report earnings on August 17, 2025, and the estimated EPS forecast is HK$-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 594.49M$ 839.53M$ 625.70M$ 490.10M$ 390.85M
Gross Profit$ 272.13M$ 270.63M$ 304.08M$ 282.52M$ 255.89M
Operating Income$ 9.28M$ 26.19M$ -438.11M$ -379.29M$ -204.55M
EBITDA$ 70.43M$ -249.42M$ -389.04M$ -477.27M$ -174.71M
Net Income$ 2.96B$ -95.48M$ -226.85M$ -358.71M$ -204.94M
Balance Sheet
Cash & Short-Term Investments$ 621.18M$ 1.93B$ 1.46B$ 1.41B$ 772.38M
Total Assets$ 5.28B$ 3.39B$ 2.55B$ 2.23B$ 1.45B
Total Debt$ 723.74M$ 416.99M$ 349.80M$ 156.45M$ 55.00M
Net Debt$ 591.75M$ -1.03B$ -674.20M$ -1.02B$ -574.05M
Total Liabilities$ 954.91M$ 1.34B$ 1.18B$ 846.17M$ 631.82M
Stockholders' Equity$ 4.32B$ 1.39B$ 1.01B$ 1.05B$ 901.71M
Cash Flow
Free Cash Flow$ -72.27M$ -444.62M$ -336.40M$ -269.83M$ -272.97M
Operating Cash Flow$ 75.65M$ -286.91M$ -120.29M$ -136.79M$ -151.09M
Investing Cash Flow$ -1.46B$ -357.73M$ -443.30M$ -212.55M$ -100.17M
Financing Cash Flow$ 66.52M$ 1.07B$ 419.32M$ 902.14M$ 624.20M
Currency in USD

Genscript Biotech Earnings and Revenue History

Genscript Biotech Debt to Assets

Genscript Biotech Cash Flow

Genscript Biotech Forecast EPS vs Actual EPS